These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15899925)

  • 21. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
    Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
    Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
    Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
    Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
    Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
    J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control.
    Naper C; Vaage JT; Lambracht D; Løvik G; Butcher GW; Wonigeit K; Rolstad B
    Eur J Immunol; 1995 May; 25(5):1249-56. PubMed ID: 7774627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of T cell reactivation by regulatory Qa-1-restricted CD8+ T cells.
    Varthaman A; Khallou-Laschet J; Clement M; Fornasa G; Kim HJ; Gaston AT; Dussiot M; Caligiuri G; Herbelin A; Kaveri S; Cantor H; Nicoletti A
    J Immunol; 2010 Jun; 184(12):6585-91. PubMed ID: 20488793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.
    Kao C; Daniels MA; Jameson SC
    Int Immunol; 2005 Dec; 17(12):1607-17. PubMed ID: 16263755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells.
    Ugolini S; Arpin C; Anfossi N; Walzer T; Cambiaggi A; Förster R; Lipp M; Toes RE; Melief CJ; Marvel J; Vivier E
    Nat Immunol; 2001 May; 2(5):430-5. PubMed ID: 11323697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid and preferential distribution of blood-borne alphaCD3epsilonAb to the liver is followed by local stimulation of T cells and natural killer T cells.
    Wingender G; Schumak B; Schurich A; Gessner JE; Endl E; Limmer A; Knolle PA
    Immunology; 2006 Jan; 117(1):117-26. PubMed ID: 16423047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells.
    Schott E; Ploegh HL
    Eur J Immunol; 2002 Dec; 32(12):3425-34. PubMed ID: 12432573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of Xenopus CD8+ T cells expressing an NK cell-associated molecule.
    Rau L; Gantress J; Bell A; Stewart R; Horton T; Cohen N; Horton J; Robert J
    Eur J Immunol; 2002 Jun; 32(6):1574-83. PubMed ID: 12115640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
    Ford MS; Chen W; Wong S; Li C; Vanama R; Elford AR; Asa SL; Ohashi PS; Zhang L
    Eur J Immunol; 2007 Aug; 37(8):2234-41. PubMed ID: 17578845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
    Falk CS; Noessner E; Weiss EH; Schendel DJ
    Cancer Res; 2002 Jan; 62(2):480-7. PubMed ID: 11809699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells.
    Agrawal S; Marquet J; Freeman GJ; Tawab A; Bouteiller PL; Roth P; Bolton W; Ogg G; Boumsell L; Bensussan A
    J Immunol; 1999 Feb; 162(3):1223-6. PubMed ID: 9973372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death.
    Radvanyi LG; Mills GB; Miller RG
    J Immunol; 1993 Jun; 150(12):5704-15. PubMed ID: 8515084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The rapid induction of HLA-E is essential for the survival of antigen-activated naive CD4 T cells from attack by NK cells.
    Takao S; Ishikawa T; Yamashita K; Uchiyama T
    J Immunol; 2010 Nov; 185(10):6031-40. PubMed ID: 20952676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha.
    Jewett A; Bonavida B
    Clin Immunol; 2000 Jul; 96(1):19-28. PubMed ID: 10873424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural killer cells and CD4+ T-cells modulate collateral artery development.
    van Weel V; Toes RE; Seghers L; Deckers MM; de Vries MR; Eilers PH; Sipkens J; Schepers A; Eefting D; van Hinsbergh VW; van Bockel JH; Quax PH
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2310-8. PubMed ID: 17717295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.